White House Archives - Medical Design Sourcing

Biden signs executive order for women’s health research and innovation

President Joe Biden [Image courtesy of the White House]President Joe Biden this week signed an executive order that will direct funds and actions toward expanding and improving research on women’s health.

The initiative builds on First Lady Jill Biden’s announcement last month in which the Advanced Research Projects Agency for Health (ARPA-H) earmarked $100 million in funds to “fundamentally change” how the U.S. approaches and funds women’s health research.

This week’s executive order follows President Biden’s March 7 State of the Union address, in which he called on Congress to invest $12 billion in new funding for women’s health research.

Biden’s executive order will create directives that will ensure women’s health is integrated and prioritized across the federal research portfolio and budget, according to the White House. It will also motivate new research on a wide range of topics in womenR…

Jill Biden launches $100M initiative to transform women’s health research

Dr. Jill Biden and the White House this week announced that $100 million in federal funding will go toward research and development into women’s health.

First Lady Dr. Jill Biden [Image courtesy of the White House]The First Lady said the funding is part of a White House Initiative on Women’s Health Research that the White House announced in November. The Federal Department of Health and Human Services set aside money from the Advanced Research Projects Agency for Health (ARPA-H) for this initiative.

In her speech in Cambridge, Massachusetts, Biden said the initiative aims to “fundamentally change” how the U.S. approaches and funds women’s health research.

“Research on women’s health has always been underfunded, many medical studies have focused on men and left women out,” Biden said. “Many of the medicine dosages, treatments, medical school textbooks, are based on men and their bodies – and that informat…

White House allocates 55M COVID-19 vaccine doses for global distribution

[Photo by Daniel Schludi on Unsplash]The Biden-Harris administration today announced a global distribution list for 55 million doses of America’s COVID-19 vaccine supply.

Biden pledged to allocate 80 million doses of the COVID-19 vaccine supply belonging to the U.S. by the end of June to aid the global fight against the pandemic. Earlier this month, the administration announced the plan for the first 25 million doses that the U.S. has begun shipping, with the remaining 55 million doses announced today.

Get the full story at our sister site, Pharmaceutical Processing World.

Amid controversy, Biden cancels Emergent Biosolutions visit

Image from René DeAnda on Unsplash

The White House scrapped plans to hold a Wednesday meeting at a Baltimore-based vaccine plant from Emergent BioSolutions following an exposé from The New York Times.

The Biden administration also announced plans to conduct an audit of the Strategic National Stockpile after the publication of the article, which described how the biopharmaceutical company lobbied the federal government to buy millions of anthrax vaccine doses.

Over the past ten years, the U.S. government has devoted almost half of its stockpile budget to BioSolutions’ anthrax vaccine, leaving a dearth of funding for pandemic response.

Get the full story from our sister site, Pharmaceutical Processing World.

BREAKING: U.S. to reportedly pay Abbott $750M for new COVID-19 tests

Multiple reports have said President Trump will announce a $750 million deal with Abbott (NYSE:ABT) for 150 million of its rapid COVID-19 antigen tests.

As first reported by Politico before being confirmed by other outlets, a White House official said that Trump will announce the deal tonight, using his speech at the Republican National Convention to confirm the news.

The U.S. Department of Health and Human Services confirmed the reports in a news release late Thursday. Trump spoke for more than an hour at the RNC but did not make an announcement related to the deal with Abbott.

“This is a major development that will help our country to remain open, get Americans back to work, and kids back to school,” White House communications director Alyssa Farah said in a statement to CNBC. “The Trump Administration is proud to partner with Abbott Labs to make this purchase possible to help the American people.”

“The introduction of Abbott’s antigen test is a…